Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal
- PMID: 9699130
- DOI: 10.1007/BF03350774
Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal
Abstract
Not only thyroid adenomas and carcinomas, but also the majority of single and well delimited goiter nodules, even if morphologically heterogeneous, are of clonal origin. However, it is still unknown whether the nodules of rapidly growing, recurrent goiters are clonal or polyclonal. We investigated by PCR-based analysis of exon 1 of the human androgen receptor gene clonality of nodules grown in recurrent multinodular goiters (MNG) of 14 female patients. The total goiter volume varied widely between 15 ml and 170 ml. The mean age of patients undergoing surgery for recurrent goiter at the time of their first operation was significantly lower with 34.6 +/- 10.9 yr in comparison to 50 consecutive patients who were operated for MNG for the first time (53.7 +/- 13.5 yr). The interval between first and recurrent operation was 18 +/- 8.5 yr. The mean volume of well circumscribed nodules selected for the present investigation was 3.8 +/- 1.4 ml. Assessment of clonality in at least 2 samples of each lesion revealed a polyclonal pattern in 10 out of 14 nodules, whereas only 3 nodules were clonal and in one case the result remained unclear. The unexpected finding that most nodules within MNG, that had re-grown after a first subtotal thyroidectomy, were of polyclonal rather than clonal composition, suggests that these lesions are generated by de novo-proliferation of cohorts of differing thyrocytes sharing the common trait of an exceedingly high intrinsic growth rate or alternatively, by unknown growth stimulating molecular events acting focally on clusters of cells derived from different ancestors. In addition, the relatively young age of patients with recurrent MNG at the time of their first surgery and the comparatively short interval between first and second operation point to a genetic element in the occurrence of growth-prone thyrocytes.
Similar articles
-
The clonality of nodules in recurrent goiters at second surgery.Langenbecks Arch Surg. 1998 Dec;383(6):453-5. doi: 10.1007/s004230050159. Langenbecks Arch Surg. 1998. PMID: 9921946
-
Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters.J Clin Endocrinol Metab. 1994 Jul;79(1):134-9. doi: 10.1210/jcem.79.1.7517946. J Clin Endocrinol Metab. 1994. PMID: 7517946
-
Analysis and prevention of recurrent goiter.Surg Gynecol Obstet. 1993 Apr;176(4):319-22. Surg Gynecol Obstet. 1993. PMID: 8460405
-
Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas.Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:32-5. doi: 10.1055/s-0029-1211697. Exp Clin Endocrinol Diabetes. 1996. PMID: 8980997 Review.
-
Nodular goiter and goiter nodules: Where iodine deficiency falls short of explaining the facts.Exp Clin Endocrinol Diabetes. 2001;109(5):250-60. doi: 10.1055/s-2001-16344. Exp Clin Endocrinol Diabetes. 2001. PMID: 11507648 Review.
Cited by
-
Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature.World J Surg. 2008 Jul;32(7):1301-12. doi: 10.1007/s00268-008-9477-0. World J Surg. 2008. PMID: 18305998 Review.
-
Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy.Arch Med Sci. 2012 May 9;8(2):263-9. doi: 10.5114/aoms.2012.28222. Arch Med Sci. 2012. PMID: 22661999 Free PMC article.
-
Nontoxic Multinodular Goitre and Incidental Thyroid Cancer: What Is the Best Surgical Strategy?-A Retrospective Study of 2032 Patients.Int J Endocrinol. 2018 May 14;2018:4735436. doi: 10.1155/2018/4735436. eCollection 2018. Int J Endocrinol. 2018. PMID: 29887888 Free PMC article.
-
[Total thyroidectomy for multinodular goiter].Chirurg. 2010 Jul;81(7):603-6, 608-11. doi: 10.1007/s00104-009-1880-z. Chirurg. 2010. PMID: 20544167 Review. German.
-
Five-year follow-up of a randomized clinical trial of unilateral thyroid lobectomy with or without postoperative levothyroxine treatment.World J Surg. 2010 Jun;34(6):1232-8. doi: 10.1007/s00268-010-0439-y. World J Surg. 2010. PMID: 20130863 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources